Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Ai Koyanagi,4 Jaume Aguado,4 Susanne Kraemer,5 Josep Maria Haro4 1Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly and Company, Windlesham, Surrey, UK; 2Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly...

Full description

Bibliographic Details
Main Authors: Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Patient Preference and Adherence
Subjects:
olanzapine
schizophrenia
bipolar disorder
orodispersible formulation
relapse
hospitalization
Online Access:https://www.dovepress.com/comparison-of-clinical-outcomes-with-orodispersible-versus-standard-or-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/comparison-of-clinical-outcomes-with-orodispersible-versus-standard-or-peer-reviewed-article-PPA

Similar Items